Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice

Journal of Psychiatry and Neuroscience

Volumn 38, Issue 3, 2013, Pages 183-191

  Lee, Younghyurk ^a   Son, Hyeonwi ^a   Kim, Gyeongwha ^a   Kim, Sujeong ^a   Lee, Dong Hoon ^a   Roh, Gu Seob ^a   Kang, Sang Soo ^a   Cho, Gyeong Jae ^a   Choi, Wan Sung ^a   Kim, Hyun Joon ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; GLUTAMINE; METHIONINE SULFOXIMINE; SUCROSE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; STATISTICAL ANALYSIS;

EID: 84876528294     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.120024     Document Type: Article

References (54)

1. Nemeroff CB. The neurobiology of depression. Sci Am 1998;278:42-49.
2. Hercher C, Turecki G, Mechawar N. Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res 2009;43:947-961.
3. Bremner JD, Vythilingam M, Vermetten E, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002;51: 273-279.
4. Drevets WC. Functional anatomical abnormalities in limbic andprefrontal cortical structures in major depression. Prog Brain Res 2000;126:413-431.
5. Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003;54:338-352.
6. Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007;6:219-233.
7. Banasr M, Duman RS. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 2007;6:311-320.
8. Miguel-Hidalgo JJ, Baucom C, Dilley G, et al. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 2000;48:861-873.
9. Fuchs E, Flugge G. Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev 1998;23:295-300.
10. Cotter D, Mackay D, Chana G, et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002;12:386-394.
11. Choudary PV, Molnar M, Evans SJ, et al. Altered cortical gluta-matergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 2005;102:15653-8.
12. Banasr M, Valentine GW, Li XY, et al. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 2007;62:496-504.
13. Czeh B, Muller-Keuker JI, Rygula R, et al. Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 2007;32:1490-1503.
14. Banasr M, Duman RS. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 2008;64:863-470.
15. Lee Y, Gaskins D, Anand A, et al. Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology (Berl) 2007;191:55-65.
16. Sanacora G, Rothman DL, Mason G, et al. Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 2003;1003:292-308.
17. Walter M, Henning A, Grimm S, et al. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry 2009;66:478-486.
18. Paxinos G, Franklin K. The mouse brain in stereotaxic coordinates. San Diego: Academic Press; 2001.
19. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-732.
20. Joo Y, Choi KM, Lee YH, et al. Chronic immobilization stress induces anxiety-and depression-like behaviors and decreases transthyretin in the mouse cortex. Neurosci Lett 2009;461:121-125.
21. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90-110.
22. Jeon BT, Shin HJ, Kim JB, et al. Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity. Brain Res Rev 2009;61:81-88.
23. Jenstad M, Quazi AZ, Zilberter M, et al. System A transporter SAT2 mediates replenishment of dendritic glutamate pools controlling retrograde signaling by glutamate. Cereb Cortex 2009;19: 1092-106.
24. Dadsetan S, Bak LK, Sorensen M, et al. Inhibition of glutamine synthesis induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons. Neuro-chem Int 2011;59:482-488.
25. Kanamori K, Ross BD. Kinetics of glial glutamine efflux and the mechanism of neuronal uptake studied in vivo in mildly hyperam-monemic rat brain. J Neurochem 2006;99:1103-1113.
26. Khurgel M, Koo AC, Ivy GO. Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate. Glia 1996;16:351-358.
27. Merkl A, Schubert F, Quante A, et al. Abnormal cingulate and pre-frontal cortical neurochemistry in major depression after electro-convulsive therapy. Biol Psychiatry 2011;69:772-779.
28. Pfleiderer B, Michael N, Erfurth A, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003; 122:185-192.
29. Hasler G, van der Veen JW, Tumonis T, et al. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007;64:193-200.
30. Ajilore O, Haroon E, Kumaran S, et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 2007;32:1224-1231.
31. Yildiz-Yesiloglu A, Ankerst DP. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 2006;147:1-25.
32. Mitani H, Shirayama Y, Yamada T, et al. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1155-1158.
33. Valentine GW, Sanacora G. Targeting glial physiology and glutamate cycling in the treatment of depression. Biochem Pharmacol 2009;78:431-439.
34. Marquez J, Tosina M, de la Rosa V, et al. New insights into brain glutaminases: beyond their role on glutamatergic transmission. Neurochem Int 2009;55:64-70.
35. Hascup KN, Hascup ER, Stephens ML, et al. Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression. Neuropsychopharmacology 2011;36:1769-1777.
36. Auer DP, Putz B, Kraft E, et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-313.
37. Michael N, Erfurth A, Ohrmann P, et al. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electrocon-vulsive therapy in patients with treatment resistant unipolar depression. Psychol Med 2003;33:1277-1284.
38. Zou J, Wang YX, Dou FF, et al. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excito-toxicity to neurons. Neurochem Int 2010;56:577-584.
39. Zink M, Vollmayr B, Gebicke-Haerter PJ, et al. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology 2010;58:465-473.
40. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005;10:808-819.
41. Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47:351-354.
42. Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-864.
43. Alt A, Nisenbaum ES, Bleakman D, et al. A role for AMPA receptors in mood disorders. Biochem Pharmacol 2006;71:1273-1288.
44. Pilc A, Chaki S, Nowak G, et al. Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 2008;75:997-1006.
45. Moghaddam B, Adams B, Verma A, et al. Activation of glutamater-gic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997;17: 2921-2927.
46. Rogers LL, Pelton RB. Effect of glutamine in IQ scores of mentally deficient children. Tex Rep Biol Med 1957;15:84-90.
47. Rogers LL, Pelton RB. Glutamine in the treatment of alcoholism; a preliminary report. Q J Stud Alcohol 1957;18:581-587.
48. Ravel JM, Felsing B, Lansford EM Jr, et al. Reversal of alcohol toxicity by glutamine. J Biol Chem 1955;214:497-501.
49. Cocchi R. Antidepressive properties of I-glutamine. Preliminary report. Acta Psychiatr Belg 1976;76:658-666.
50. Cocchi R, Tornati A. Psychic dependence? A different formulation of the problem with a view to the reorientation of therapy for chronic drug addiction. Acta Psychiatr Scand 1977;56:337-346.
51. Lowe DK, Benfell K, Smith RJ, et al. Safety of glutamine-enriched parenteral nutrient solutions in humans. Am J Clin Nutr 1990;52:1101-6.
52. Stehle P, Zander J, Mertes N, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1989;1:231-233.
53. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992;116:821-828.
54. Young LS, Bye R, Scheltinga M, et al. Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood. JPEN J Parenter Enteral Nutr 1993;17:422-427.